Statistics

Total Visits

Views
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial 845

Total Visits per Month

December 2024 January 2025 February 2025 March 2025 April 2025 May 2025 June 2025
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial 27 23 29 33 22 34 4

File Downloads

Views
Kyriazopoulou.pdf 314

Top Country Views

Views

Top City Views

Views